Natural Course of Human T-Cell Leukemia Virus Type 1 Proviral DNA Levels in Carriers During Pregnancy

The measurement of human T-cell leukemia virus type 1 (HTLV-1) proviral DNA levels by using polymerase chain reaction has been beneficial for confirming HTLV-1 infection during pregnancy. However, the influence of pregnancy on HTLV-1 infection and proviral DNA levels among pregnant women with HTLV-1 has not been clarified. We prospectively gathered blood samples from 36 pregnant women in whom HTLV-1 carriage was previously diagnosed and sequentially measured their proviral DNA levels. The HTLV-1 proviral DNA levels remained at a plateau during pregnancy but were elevated after delivery. Moreover, flow cytometry and serological analyses revealed that the regulatory T-cell population and soluble interleukin 2 receptor levels were similarly elevated after birth in comparison with those in control pregnant women. This study is the first to provide data on sequential changes in HTLV-1 proviral DNA levels during and after pregnancy. These findings will guide the establishment of a better program to prevent mother-to-child transmission of HTLV-1.

[1]  S. Hanada,et al.  Treatment and survival among 1594 patients with ATL. , 2015, Blood.

[2]  S. Saito,et al.  Standardization of Quantitative PCR for Human T-Cell Leukemia Virus Type 1 in Japan: a Collaborative Study , 2015, Journal of Clinical Microbiology.

[3]  Steven Jacobson,et al.  Digital droplet PCR (ddPCR) for the precise quantification of human T-lymphotropic virus 1 proviral loads in peripheral blood and cerebrospinal fluid of HAM/TSP patients and identification of viral mutations , 2014, Journal of NeuroVirology.

[4]  Shunji Suzuki,et al.  Current status of HTLV-1 carrier in Japanese pregnant women , 2014, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[5]  S. Katamine,et al.  Mother-to-child transmission of human T-cell lymphotropic virus type 1. , 2013, The Pediatric infectious disease journal.

[6]  A. Saitoh,et al.  Discrepancy between human T‐cell lymphotropic virus type I screening test and confirmatory tests in non‐endemic areas , 2012, The journal of obstetrics and gynaecology research.

[7]  M. Matsuoka,et al.  HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals , 2012, Retrovirology.

[8]  S. Coughlan,et al.  Multiplex real-time PCR for the detection and quantitation of HTLV-1 and HTLV-2 proviral load: addressing the issue of indeterminate HTLV results. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[9]  M. Satake,et al.  Intra‐ and inter‐laboratory variability in human T‐cell leukemia virus type‐1 proviral load quantification using real‐time polymerase chain reaction assays: A multi‐center study , 2010, Cancer science.

[10]  K. Yamaguchi,et al.  Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. , 2010, Blood.

[11]  M. Sayegh,et al.  Maternal Acceptance of the Fetus: True Human Tolerance , 2007, The Journal of Immunology.

[12]  Elizabeth M. Maloney,et al.  Natural history of viral markers in children infected with human T lymphotropic virus type I in Jamaica. , 2006, The Journal of infectious diseases.

[13]  T. Gingeras,et al.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.

[14]  R. Wilks,et al.  Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I. , 2006, The Journal of infectious diseases.

[15]  M. Tomonaga,et al.  Possible origin of adult T‐cell leukemia/lymphoma cells from human T lymphotropic virus type‐1‐infected regulatory T cells , 2005, Cancer science.

[16]  A. G. Betz,et al.  Regulatory T cells mediate maternal tolerance to the fetus , 2004, Nature Immunology.

[17]  M. Matsuoka,et al.  Genetic evidence of transmission of human T cell lymphotropic virus type 1 between spouses. , 2002, The Journal of infectious diseases.

[18]  M. Matsuoka,et al.  Sequential change of virus markers in seroconverters with community-acquired infection of human T lymphotropic virus type I. , 2001, The Journal of infectious diseases.

[19]  W. Blattner,et al.  Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. , 1999, The Journal of infectious diseases.

[20]  M. Matsuoka,et al.  Rapid quantification of HTLV‐I provirus load: Detection of monoclonal proliferation of HTLV‐I‐infected cells among blood donors , 1999, International Journal of Cancer.

[21]  M. Matsuoka,et al.  Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. , 1997, Cancer research.

[22]  S. Katamine,et al.  Primary prevention of HTLV-1 in Japan. , 1997, Leukemia.

[23]  J. Goedert,et al.  Modelling the risk of adult T‐cell leukemia/lymphoma in persons infected with human T‐lymphotropic virus type I , 1989, International journal of cancer.